SPAR Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SPAR Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $181.38M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $134.32M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $119.28M | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $122.02M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $111.96M | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $98.55M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $73.52M | Apr 2, 2013 |
| FY2011 | Dec 31, 2010 | $63.15M | Mar 21, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.69M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $33.60M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $8.44M | Jul 17, 2025 |
| FY2024 | Jun 30, 2024 | $8.96M | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $44.44M | Jul 17, 2025 |
| FY2024 | Sep 30, 2023 | $10.64M | Jul 17, 2025 |
| FY2024 | Jun 30, 2023 | $10.20M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $51.01M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $47.52M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $45.19M | Apr 15, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($24.63M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($3.15M) | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | ($182.0K) | Jul 17, 2025 |
| FY2024 | Jun 30, 2024 | ($3.89M) | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $3.90M | Jul 17, 2025 |
| FY2024 | Sep 30, 2023 | $259.0K | Jul 17, 2025 |
| FY2024 | Jun 30, 2023 | $639.0K | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | ($732.0K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.00M | May 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.37M | Apr 15, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($16.90M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $700.0K | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | ($1.53M) | Jul 17, 2025 |
| FY2024 | Jun 30, 2024 | ($966.0K) | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $5.58M | Jul 17, 2025 |
| FY2024 | Sep 30, 2023 | $800.0K | Jul 17, 2025 |
| FY2024 | Jun 30, 2023 | $958.0K | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $5.39M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.18M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.72M | Apr 15, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.20M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $33.88M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $8.56M | Jul 17, 2025 |
| FY2024 | Jun 30, 2024 | $8.07M | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $36.63M | Jul 17, 2025 |
| FY2024 | Sep 30, 2023 | $9.34M | Jul 17, 2025 |
| FY2024 | Jun 30, 2023 | $8.80M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $41.14M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $36.78M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $33.34M | Apr 15, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.44M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($665.0K) | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | ($730.0K) | Jul 17, 2025 |
| FY2024 | Jun 30, 2024 | $170.0K | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $6.82M | Jul 17, 2025 |
| FY2024 | Sep 30, 2023 | $1.64M | Jul 17, 2025 |
| FY2024 | Jun 30, 2023 | $6.74M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | ($5.04M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.63M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $8.80M | Apr 15, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.06M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $56.43M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $67.40M | May 16, 2025 |
| FY2024 | Jun 30, 2024 | $70.03M | May 16, 2025 |
| FY2024 | Dec 31, 2023 | $90.28M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $94.60M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $89.02M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $84.03M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $79.54M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $69.10M | Apr 14, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.44M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $32.13M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $37.86M | May 16, 2025 |
| FY2024 | Jun 30, 2024 | $39.33M | May 16, 2025 |
| FY2024 | Dec 31, 2023 | $50.04M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $56.54M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $51.67M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $45.41M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $48.17M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $44.32M | Apr 14, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $24.31M | Jul 17, 2025 |
| FY2024 | Sep 30, 2024 | $29.30M | May 16, 2025 |
| FY2024 | Jun 30, 2024 | $29.38M | May 16, 2025 |
| FY2024 | Dec 31, 2023 | $28.23M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $22.43M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $19.75M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $22.16M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $18.96M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $16.30M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $19.65M | Apr 24, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $856.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $856.0K | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $1.24M | May 16, 2025 |
| FY2024 | Jun 30, 2024 | $1.24M | May 16, 2025 |
| FY2024 | Dec 31, 2023 | $1.29M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $1.71M | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | $4.17M | Apr 1, 2024 |
| FY2021 | Dec 31, 2020 | $3.76M | Apr 15, 2022 |
| FY2021 | Dec 31, 2019 | $3.78M | Apr 15, 2022 |
| FY2019 | Dec 31, 2018 | $3.79M | Apr 14, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($17.17M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $7.46M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $12.45M | May 16, 2025 |
| FY2024 | Jun 30, 2024 | $12.63M | May 16, 2025 |
| FY2024 | Dec 31, 2023 | $10.61M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $6.71M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $7.44M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.22M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $5.85M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.43M | Apr 14, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.26M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $18.22M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $19.65M | May 16, 2025 |
| FY2024 | Jun 30, 2024 | $21.70M | May 16, 2025 |
| FY2024 | Dec 31, 2023 | $4.49M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $9.35M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $13.47M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $15.97M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $10.46M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $7.11M | Apr 14, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $6.44M | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | $4.31M | Apr 15, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | 0 | Jul 17, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jul 17, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Jul 17, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 15, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | 0 | Jul 17, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jul 17, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Jul 17, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 15, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24.13M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 23.45M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 23.24M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | 23.06M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 21.32M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 21.12M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 21.10M | Mar 31, 2021 |
| FY2012 | Dec 31, 2012 | 20.46M | Apr 2, 2013 |
| FY2012 | Dec 31, 2011 | 20.10M | Apr 2, 2013 |
| FY2011 | Dec 31, 2010 | 19.31M | Mar 21, 2012 |